Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Greaves, Ronda / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter


IMPACT FACTOR 2018: 3.638

CiteScore 2018: 2.44

SCImago Journal Rank (SJR) 2018: 1.191
Source Normalized Impact per Paper (SNIP) 2018: 1.205

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 57, Issue 11

Issues

Unexpected analytical interference in isavuconazole UV determination in a child in therapy with lumacaftor/ivacaftor for cystic fibrosis

Sara Baldelli / Marta Fusi / Valeria Cozzi / Emilio Clementi
  • Clinical Pharmacology Unit, Consiglio Nazionale delle Ricerche Institute of Neuroscience, Department of Biomedical and Clinical Sciences L. Sacco University Hospital, Università degli Studi di Milano, Milan, Italy
  • E. Medea Scientific Institute, Bosisio Parini, Italy
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Nadia Maria Luisa Faelli
  • Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Centro Regionale di Riferimento per la Fibrosi Cistica, Università degli Studi di Milano, Milan, Italy
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Maria Russo
  • Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Centro Regionale di Riferimento per la Fibrosi Cistica, Università degli Studi di Milano, Milan, Italy
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Carla Colombo
  • Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Centro Regionale di Riferimento per la Fibrosi Cistica, Università degli Studi di Milano, Milan, Italy
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Dario Cattaneo
Published Online: 2019-05-29 | DOI: https://doi.org/10.1515/cclm-2019-0192

References

  • 1.

    Miceli MH, Kauffman CA. Isavuconazole: a new broad-spectrum triazole antifungal agent. Clin Infect Dis 2015;61:1558–65.CrossrefWeb of SciencePubMedGoogle Scholar

  • 2.

    Jović Z, Janković SM, Ružić Zečević D, Milovanović D, Stefanović S, Folić M, et al. Clinical pharmacokinetics of second-generation triazoles for the treatment of invasive aspergillosis and candidiasis. Eur J Drug Metab Pharmacokinet 2019;44:139–57.CrossrefPubMedWeb of ScienceGoogle Scholar

  • 3.

    Desai A, Yamazaki T, Dietz AJ, Kowalski D, Lademacher C, Pearlman H, et al. Pharmacokinetic and pharmacodynamic evaluation of the drug-drug interaction between isavuconazole and warfarin in healthy subjects. Clin Pharmacol Drug Dev 2017;6:86–92.Web of SciencePubMedCrossrefGoogle Scholar

  • 4.

    Andes DR, Ghannoum MA, Mukherjee PK, Kovanda LL, Lu Q, Jones ME, et al. Outcomes by MIC values for patients treated with isavuconazole or voriconazole for invasive aspergillosis in the phase 3 SECURE and VITAL trials. Antimicrob Agents Ch 2018;63. pii: e01634-18.Web of ScienceGoogle Scholar

  • 5.

    Rivosecchi RM, Samanta P, Demehin M, Nguyen MH. Pharmacokinetics of azole antifungals in cystic fibrosis. Mycopathologia 2018;183:139–50.PubMedCrossrefWeb of ScienceGoogle Scholar

  • 6.

    Billaud EM, Guillemain R, Berge M, Amrein C, Lefeuvre S, Louët AL, et al. Pharmacological considerations for azole antifungal drug management in cystic fibrosis lung transplant patients. Med Mycol 2010;48(Suppl 1):S52–9.PubMedCrossrefWeb of ScienceGoogle Scholar

  • 7.

    Kabulski GM, MacVane SH. Isavuconazole pharmacokinetics in a patient with cystic fibrosis following bilateral orthotopic lung transplantation. Transpl Infect Dis 2018;20:e12878.Web of ScienceCrossrefGoogle Scholar

  • 8.

    Cozzi V, Baldelli S, Castoldi S, Clementi E, Cattaneo D. Development and validation of a chromatographic ultraviolet method for the quantification of isavuconazole in human plasma samples. Ther Drug Monit 2018;40:512–4.PubMedWeb of ScienceCrossrefGoogle Scholar

  • 9.

    Arsiè E, Piconi S, Iavarone M, Cozzi V, Lampertico P, Cattaneo D. High isavuconazole plasma levels in a patient with possible invasive pulmonary aspergillosis and cirrhosis. Eur J Clin Pharmacol 2018;74:1089–90.Web of ScienceCrossrefGoogle Scholar

About the article

Corresponding author: Sara Baldelli, Chem.D, Unit of Clinical Pharmacology, Luigi Sacco University Hospital, ASST Fatebenefratelli Sacco, via GB Grassi 74, 20157 Milan, Italy, Phone: 00390250319619, Fax: 00390250119646


Received: 2019-02-19

Accepted: 2019-05-01

Published Online: 2019-05-29

Published in Print: 2019-10-25


Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

Research funding: None declared.

Employment or leadership: None declared.

Honorarium: None declared.

Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.


Citation Information: Clinical Chemistry and Laboratory Medicine (CCLM), Volume 57, Issue 11, Pages e274–e278, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/cclm-2019-0192.

Export Citation

©2019 Walter de Gruyter GmbH, Berlin/Boston.Get Permission

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Reactions Weekly, 2019, Volume 1757, Number 1, Page 180

Comments (0)

Please log in or register to comment.
Log in